Work

A randomized phase II study of androgen deprivation therapy with or without PD0332991 in RB-positive metastatic hormone-sensitive prostate cancer.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.tps5074

Authors: Phillip Lee Palmbos, Felix Yi-Chung Feng, Scott A. Tomlins, William Kevin Kelly, Alicia Katherine Morgans, Mary-Ellen Taplin, Neeraj Agarwal, Emmanuel S. Antonarakis, Przemyslaw Twardowski, Jon Jacobson, Matthew S. Davenport, Stephanie Daignault, Karen E. Knudsen, Maha Hussain

Institutions: Michigan Medicine, Thomas Jefferson University, Sidney Kimmel Cancer Center, Vanderbilt University Medical Center, Harvard University, Dana-Farber Cancer Institute, Huntsman Cancer Institute, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, City Of Hope National Medical Center, City of Hope, U-M Rogel Cancer Center, University of Michigan

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2597316429

Cites:

Cited by: 1

Related to: 10